Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01139723
Title A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Encinitas California 92008 United States Details
Los Angeles California 90095 United States Details
Aurora Colorado 80045 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field